Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain.
Knutson KL, Clynes R, Shreeder B, Yeramian P, Kemp KP, Ballman K, Tenner KS, Erskine CL, Norton N, Northfelt D, Tan W, Calfa C, Pegram M, Mittendorf EA, Perez EA. Knutson KL, et al. Among authors: shreeder b. Cancer Res. 2016 Jul 1;76(13):3702-10. doi: 10.1158/0008-5472.CAN-15-3091. Epub 2016 Apr 20. Cancer Res. 2016. PMID: 27197192 Free PMC article. Clinical Trial.
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.
Lamichhane P, Karyampudi L, Shreeder B, Krempski J, Bahr D, Daum J, Kalli KR, Goode EL, Block MS, Cannon MJ, Knutson KL. Lamichhane P, et al. Among authors: shreeder b. Cancer Res. 2017 Dec 1;77(23):6667-6678. doi: 10.1158/0008-5472.CAN-17-0740. Epub 2017 Oct 9. Cancer Res. 2017. PMID: 28993412 Free PMC article.
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients.
Kalli KR, Block MS, Kasi PM, Erskine CL, Hobday TJ, Dietz A, Padley D, Gustafson MP, Shreeder B, Puglisi-Knutson D, Visscher DW, Mangskau TK, Wilson G, Knutson KL. Kalli KR, et al. Among authors: shreeder b. Clin Cancer Res. 2018 Jul 1;24(13):3014-3025. doi: 10.1158/1078-0432.CCR-17-2499. Epub 2018 Mar 15. Clin Cancer Res. 2018. PMID: 29545464 Free PMC article. Clinical Trial.
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma.
Yin N, Liu Y, Weems C, Shreeder B, Lou Y, Knutson KL, Murray NR, Fields AP. Yin N, et al. Among authors: shreeder b. Sci Transl Med. 2022 Nov 16;14(671):eabq5931. doi: 10.1126/scitranslmed.abq5931. Epub 2022 Nov 16. Sci Transl Med. 2022. PMID: 36383684 Free PMC article.
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.
Luo Y, Shreeder B, Jenkins JW, Shi H, Lamichhane P, Zhou K, Bahr DA, Kurian S, Jones KA, Daum JI, Dutta N, Necela BM, Cannon MJ, Block MS, Knutson KL. Luo Y, et al. Among authors: shreeder b. J Immunother Cancer. 2023 Nov;11(11):e007661. doi: 10.1136/jitc-2023-007661. J Immunother Cancer. 2023. PMID: 37918918 Free PMC article.
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.
Wickland DP, McNinch C, Jessen E, Necela B, Shreeder B, Lin Y, Knutson KL, Asmann YW. Wickland DP, et al. Among authors: shreeder b. J Immunother Cancer. 2024 May 15;12(5):e008988. doi: 10.1136/jitc-2024-008988. J Immunother Cancer. 2024. PMID: 38754917 Free PMC article.
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma.
Gabriel EM, Necela B, Bahr D, Vivekanandhan S, Shreeder B, Bagaria S, Knutson KL. Gabriel EM, et al. Among authors: shreeder b. Res Sq [Preprint]. 2024 Apr 3:rs.3.rs-4004491. doi: 10.21203/rs.3.rs-4004491/v1. Res Sq. 2024. Update in: Sci Rep. 2024 Oct 19;14(1):24545. doi: 10.1038/s41598-024-76209-z PMID: 38645250 Free PMC article. Updated. Preprint.